Inherited p40phox deficiency differs from classic chronic granulomatous disease

Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40phox subunit of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 p40phox-deficient patients from 12 additional families in 8 countries. These patients display 8 different in-frame or out-of-frame mutations of NCF4 that are homozygous in 11 of the families and compound heterozygous in another. When overexpressed in NB4 neutrophil-like cells and EBV-transformed B cells in vitro, the mutant alleles were found to be LOF, with the exception of the p.R58C and c.120_134del alleles, which were hypomorphic. Particle-induced NADPH oxidase activity was severely impaired in the patients’ neutrophils, whereas PMA-induced dihydrorhodamine-1,2,3 (DHR) oxidation, which is widely used as a diagnostic test for chronic granulomatous disease (CGD), was normal or mildly impaired in the patients. Moreover, the NADPH oxidase activity of EBV-transformed B cells was also severely impaired, whereas that of mononuclear phagocytes was normal. Finally, the killing of Candida albicans and Aspergillus fumigatus hyphae by neutrophils was conserved in these patients, unlike in patients with CGD. The patients suffer from hyperinflammation and peripheral infections, but they do not have any of the invasive bacterial or fungal infections seen in CGD. Inherited p40phox deficiency underlies a distinctive condition, resembling a mild, atypical form of CGD.

[1]  F. Rieux-Laucat,et al.  Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study , 2018, Journal of Crohn's & colitis.

[2]  A. Schambach,et al.  Hematopoietic stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial infections. , 2018, Blood.

[3]  J. Casanova,et al.  Alanine‐scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss‐ or gain‐of‐function variants , 2017, The Journal of allergy and clinical immunology.

[4]  J. Casanova,et al.  Visceral leishmaniasis in two patients with IL‐12p40 and IL‐12Rβ1 deficiencies , 2017, Pediatric blood & cancer.

[5]  Mallary C Greenlee-Wacker,et al.  IFN‐γ targets macrophage‐mediated immune responses toward Staphylococcus aureus , 2017, Journal of leukocyte biology.

[6]  M. Dinauer,et al.  PI(3)P‐p40phox binding regulates NADPH oxidase activation in mouse macrophages and magnitude of inflammatory responses in vivo , 2017, Journal of leukocyte biology.

[7]  R. Gavrieli,et al.  Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients , 2017, American journal of hematology.

[8]  WinterSusann,et al.  A Reduction in Intracellular Reactive Oxygen Species Due to a Mutation in NCF4 Promotes Autoimmune Arthritis in Mice. , 2016 .

[9]  S. Brant,et al.  Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease , 2016, Inflammatory bowel diseases.

[10]  J. Casanova,et al.  Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. , 2016, The Journal of allergy and clinical immunology.

[11]  S. Holland,et al.  Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  T. K. van den Berg,et al.  Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects , 2016, The Journal of Immunology.

[13]  L. Bezrodnik,et al.  Clinical and Genotypic Spectrum of Chronic Granulomatous Disease in 71 Latin American Patients: First Report from the LASID Registry , 2015, Pediatric blood & cancer.

[14]  A. Corveleyn,et al.  PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome , 2015, Journal of Clinical Immunology.

[15]  J. Casanova,et al.  Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-γR1 or IFN-γR2 deficiency. , 2015, The Journal of allergy and clinical immunology.

[16]  S. Holland,et al.  Common severe infections in chronic granulomatous disease. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  A. Mahfoudh,et al.  Lupus érythémateux disséminé et granulomatose septique chronique : à propos d’un cas , 2014 .

[18]  A. Fischer,et al.  Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. , 2014, The Journal of allergy and clinical immunology.

[19]  M. Dinauer,et al.  Two CGD Families with a Hypomorphic Mutation in the Activation Domain of p67phox. , 2014, Journal of clinical & cellular immunology.

[20]  R. Holmdahl,et al.  Deficient Production of Reactive Oxygen Species Leads to Severe Chronic DSS-Induced Colitis in Ncf1/p47phox-Mutant Mice , 2014, PloS one.

[21]  Mallary C Greenlee-Wacker,et al.  Phagocytosis of Staphylococcus aureus by Human Neutrophils Prevents Macrophage Efferocytosis and Induces Programmed Necrosis , 2014, The Journal of Immunology.

[22]  D. Roos,et al.  Molecular diagnosis of chronic granulomatous disease , 2014, Clinical and experimental immunology.

[23]  I. Tezcan,et al.  Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. , 2013, The Journal of allergy and clinical immunology.

[24]  M. Dinauer,et al.  Regulation of the NADPH Oxidase and Associated Ion Fluxes During Phagocytosis , 2013, Traffic.

[25]  Aleksey A. Porollo,et al.  Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. , 2013, Immunity.

[26]  T. K. van den Berg,et al.  Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations. , 2013, Blood.

[27]  P. Hawkins,et al.  Activation of the neutrophil NADPH oxidase by Aspergillus fumigatus , 2012, Annals of the New York Academy of Sciences.

[28]  K. Krause,et al.  Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells , 2012, The Journal of pathology.

[29]  M. Dinauer,et al.  Activation of neutrophil respiratory burst by fungal particles requires phosphatidylinositol 3-phosphate binding to p40(phox) in humans but not in mice. , 2012, Blood.

[30]  M. Dinauer,et al.  Cutting Edge: NADPH Oxidase Modulates MHC Class II Antigen Presentation by B Cells , 2012, The Journal of Immunology.

[31]  R. Xavier,et al.  p40phox Expression Regulates Neutrophil Recruitment and Function during the Resolution Phase of Intestinal Inflammation , 2012, The Journal of Immunology.

[32]  N. Hunt,et al.  Gp91phox contributes to the development of experimental inflammatory bowel disease , 2011, Immunology and cell biology.

[33]  S. Holland,et al.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. , 2011, The Journal of allergy and clinical immunology.

[34]  J. Casanova,et al.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease , 2011, Nature Immunology.

[35]  S. Holland,et al.  Residual NADPH oxidase and survival in chronic granulomatous disease. , 2010, The New England journal of medicine.

[36]  W. Janssen,et al.  Impaired Phagocytosis of Apoptotic Cells by Macrophages in Chronic Granulomatous Disease Is Reversed by IFN-γ in a Nitric Oxide-Dependent Manner , 2010, The Journal of Immunology.

[37]  J. Casanova,et al.  Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN‐γ receptor 1 deficiency , 2010, American journal of medical genetics. Part A.

[38]  Xing Jun Li,et al.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. , 2009, Blood.

[39]  Dirk Roos,et al.  Chronic Granulomatous Disease: The European Experience , 2009, PloS one.

[40]  D. Riches,et al.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4. , 2009, Blood.

[41]  M. Novelli,et al.  Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease , 2009, The American Journal of Gastroenterology.

[42]  M. Turner,et al.  Chronic granulomatous disease as a risk factor for autoimmune disease. , 2008, The Journal of allergy and clinical immunology.

[43]  S. Rosenzweig Inflammatory Manifestations in Chronic Granulomatous Disease (CGD) , 2008, Journal of Clinical Immunology.

[44]  V. Wahn,et al.  Novel cell death program leads to neutrophil extracellular traps , 2007, The Journal of Cell Biology.

[45]  P. Hawkins,et al.  Neutrophils from p40phox−/− mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing , 2006, The Journal of experimental medicine.

[46]  M. Dinauer,et al.  p40phox: the last NADPH oxidase subunit. , 2005, Blood cells, molecules & diseases.

[47]  R. Hennekam,et al.  Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship. , 2005, Blood.

[48]  E. Génin,et al.  Estimating the age of rare disease mutations: the example of Triple-A syndrome , 2004, Journal of Medical Genetics.

[49]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[50]  S. Holland,et al.  Genetic, biochemical, and clinical features of chronic granulomatous disease. , 2000, Medicine.

[51]  S. Sehgal,et al.  Chronic granulomatous disease. , 1999, Indian pediatrics.

[52]  L. Zentilin,et al.  Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. , 1998, Journal of immunology.

[53]  H. Rosen,et al.  Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli , 1997, Infection and immunity.

[54]  E. Green,et al.  Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex. , 1996, Blood.

[55]  L. V. Van Pelt,et al.  Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. , 1996, Journal of immunological methods.

[56]  A. Segal,et al.  Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils. , 1991, Journal of medical microbiology.

[57]  T. Medsger,et al.  Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. , 1991, Arthritis and rheumatism.

[58]  S. Orkin,et al.  The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex , 1987, Nature.

[59]  A. Monaco,et al.  Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location , 1986, Nature.

[60]  A. Segal,et al.  Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. , 1983, The New England journal of medicine.

[61]  D. Roos,et al.  Phagocytosing human neutrophils inactivate their own granular enzymes. , 1981, The Journal of clinical investigation.

[62]  J. Repine,et al.  Quantitative measurement of the bactericidal capability of neutrophils from patients and carriers of chronic granulomatous disease. , 1977, The Journal of laboratory and clinical medicine.

[63]  Schraibman Ig,et al.  Letter: Intravenous regional sympathetic block with guanethidine. , 1974 .

[64]  R. Lehrer,et al.  Interaction of Candida albicans with Human Leukocytes and Serum , 1969, Journal of bacteriology.

[65]  R. Good,et al.  Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. , 1966, Lancet.